Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Manganese induces podocyte injury through regulating MTDH/ALKBH5/NLRP10 axis: Combined analysis at epidemiology and molecular biology levels. | Environ Int | 2024 | 38648691 | PubTator, text mining | PubMed |
| High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11. | Environ Toxicol | 2024 | 38642004 | PubTator, text mining | PubMed |
| ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host. | Noncoding RNA Res | 2024 | 38638146 | PubTator, text mining | PubMed |
| ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer. | J Ovarian Res | 2024 | 38637813 | PubTator, text mining | PubMed |
| RNA m6A modification, signals for degradation or stabilisation? | Biochem Soc Trans | 2024 | 38629637 | PubTator, text mining | PubMed |
| Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification. | Sci Rep | 2024 | 38600232 | PubTator, text mining | PubMed |
| Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sjögren's syndrome. | Heliyon | 2024 | 38596085 | PubTator, text mining | PubMed |
| HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer. | J Exp Clin Cancer Res | 2024 | 38589927 | PubTator, text mining | PubMed |
| Palmatine inhibits expression fat mass and obesity associated protein (FTO) and exhibits a curative effect in dextran sulfate sodium (DSS)-induced experimental colitis. | Int Immunopharmacol | 2024 | 38579565 | PubTator, text mining | PubMed |
| A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO. | RSC Chem Biol | 2024 | 38576724 | PubTator, text mining | PubMed |
| Characterization of the m6A regulators' landscape highlights the clinical significance of acute myocardial infarction. | Front Immunol | 2024 | 38571952 | PubTator, text mining | PubMed |
| A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles. | Cell Rep | 2024 | 38568805 | PubTator, text mining | PubMed |
| Correction to: BMP2 Modified by the m6A Demethylation Enzyme ALKBH5 in the Ossification of the Ligamentum Flavum Through the AKT Signaling Pathway. | Calcif Tissue Int | 2024 | 38557868 | PubTator, text mining | PubMed |
| Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2. | Arch Biochem Biophys | 2024 | 38555043 | PubTator, text mining | PubMed |
| Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape. | Mol Cancer Res | 2024 | 38546386 | PubTator, text mining | PubMed |
| Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation. | Biomed Pharmacother | 2024 | 38537580 | PubTator, text mining | PubMed |
| m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB. | Cancer Res | 2024 | 38536119 | PubTator, text mining | PubMed |
| NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma. | Technol Health Care | 2024 | 38517815 | PubTator, text mining | PubMed |
| FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation. | Theranostics | 2024 | 38505602 | PubTator, text mining | PubMed |
| ALKBH5 promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating TTI1 expression. | Biomol Biomed | 2024 | 38501918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=25